A cross-talk between TGF-β and VEGF/PLGF signaling in glioblastoma was shown to have both pro- and anti-angiogenic activities in human brain-derived microvascular endothelial cells (hCMECs) and glioblastoma-derived endothelial cells (GMECs). The gene discussed is PGF; the disease is glioblastoma.